Abstract:Jing Xu, Xiaomin Shi, Youjin Pan Department of Endocrinology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China Correspondence: Youjin Pan Department of Endocrinology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Lucheng District, Wenzhou, Zhejiang Province, People's Republic of China Tel +86 15068256508 Fax +86 577-85678813 Email Purpose: To investigate the relationship between aspartate aminotransferase to alanine aminotransferase ratio (AST/ALT) and diabetic nephropathy (DN). Patients and Methods: A total of 402 patients with type 2 diabetes mellitus were divided into three groups, such as normoalbuminuria (n = 196), microalbuminuria (n = 131) and macroalbuminuria (n = 75) groups. Basic information and laboratory results were collected. Serum AST/ALT, tumor necrosis factor-α (TNF-α), interleukin (IL)-2, IL-4, IL-6, IL-10 and interferon- γ (INF- γ) were also measured. DN was defined as microalbuminuria or macroalbuminuria. The estimated glomerular filtration rate (eGFR) was calculated using the following formula: 186 × (serum creatinine) − 1.154 × (age) − 0.203 × (0.742 if female). Results: The AST/ALT in the macroalbuminuria group was higher than in the microalbuminuria and normoalbuminuria groups. The concentrations of tumor necrosis factor-α (TNF-α), IL-2, IL-4, IL-10 and INF-γ in the macroalbuminuria group were significantly higher than those in the two other groups. Multivariate logistical analysis showed that after adjusting confounding factors, TNF-α and high AST/ALT were independent risks for DN and macroalbuminuria. Furthermore, the AST/ALT had significantly positive correlation with TNF-α (r = 0.101, P = 0.048), IL-4 (r = 0.185, P = 0.005) and IL-6 (r = 0.274, P < 0.001) levels. Conclusion: This study showed that high AST/ALT was an independent risk factor for the DN. Additionally, AST/ALT was positively correlated with inflammation cytokines, such as TNF-α, IL-4 and IL-6 levels. Keywords: AST/ALT, diabetic nephropathy, inflammatory factors, tumor necrosis factor-α China has the highest incidence rate of diabetes mellitus in the world, and there is a growing trend. In China, the latest publications show that the prevalence of diabetes mellitus has risen to 12.8% nationwide. 1 By the year 2045, an estimated 693 million people had diabetes mellitus. 2 DN affects about 25% of patients with type 2 diabetes mellitus (T2DM), which is the main cause of end-stage renal disease (ESRD) in high income countries. 3,4 In addition, the cardiovascular risk of DN is very high, and the cardiovascular risk is similar to that of patients with coronary heart disease. 5,6 Therefore, it is very important to identify and manage the risk factors of DN and diagnose and treat the disease in time. Serum transaminase, aspartate transaminase (AST) and alanine transaminase (ALT) are routine indexes of liver function. In 1957, the serum AST and ALT activity ratio of was first proposed as De Ritis ratio. 7 AST/ALT is correlated with oxidative stress and systemic inflammation. 8 Although it was originally proposed as a feature of viral hepatitis, such a ratio seems to serve as a practical biomarker for other diseases. It has been reported that AST/ALT is correlated with chronic kidney disease (CKD) and metabolic syndrome (MetS). 9,10 However, there are no studies about the relationship between AST/ALT and DN. Inflammation plays a crucial role in the development and progression of DN, as many inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor α (TNF-α) contribute in the pathogenesis of DN. 8 This study aims to analyze the correlation between AST/ALT and inflammatory factors and DN. Patients with type 2 diabetes (T2DM) were recruited in Department of Endocrinology, the second affiliated hospital of Wenzhou Medical University from October 2019 to March 2021. There were 402 T2DM patients aged 40–83 years with complete data. According to the American Diabetes Association standard, the 75g oral glucose tolerance test was diagnosed as diabetes mellitus. The exclusion criteria included type 1 diabetes, alcohol consumption equal to or greater than 20g/day in the last 3 month, viral or autoimmune hepatitis, previous diagnosis of acute or chronic liver disease, intake of hepatotoxic drugs, inflammatory diseases, malignancy. All participants in our study were divided into three group, such as diabetes mellitus with normoalbuminuria (n=196), microalbuminuria (n=131) and macroalbuminuria (n=75) groups. This study was approved by the Ethics Committee of the Second Aff -Abstract Truncated-

MACRO-ASPARTATE AMINOTRANSFERASE

"Activation" of macro-AST by pyridoxal-5-phosphate in the assay for aspartate aminotransferase

Persistent elevation of aspartate aminotransferase in a child after incomplete Kawasaki disease: a case report and literature review

Clinical and Laboratory Features of Macrophage Activation Syndrome

A-125 Difference Between the Results of Vitros® Dry Biochemistry and Wet Biochemistry with Kinetic Method in Diagnosing the Comorbidity of Lung Adenocarcinoma and Aacroamylasemia: Case Report

The significance of isolated aspartate aminotransferase elevation in healthy paediatric patients

Aminotransferase activities in mouse, Mus domesticus, erythrocytes separated according to age

Diagnostic Value of Serum m-AST in Patients with Chronic Hepatopathy

Macrolipasemia variant of macroenzymes: An endocrine laboma

Study on the Measurement and Application of Mitochondrial AST by Using Automatic Analyzer

Optimization of methods for aspartate aminotransferase and alanine aminotransferase.

Macroamylasemia in a 5‐Year‐Old Girl

The Changes and Diagnostic Value of Serum m-AST Level in Patients with Acute Myocardial Infarction

Detection of macroenzymes: establishing upper reference limits for eight enzymes after polyethylene glycol precipitation

Blood AST, ALT and UREA/BUN Level Analysis

Comparison of blood aminotransferase methods for assessment of myopathy and hepatopathy in Florida manatees (Trichechus manatus latirostris)

Differential Pulse Voltammetric Determination of Serum Aspartate Amino-Transferase Activity Using DCIP As Redox Mediator at a Gold Micro Electrode

Measurement of aspartate carbamoyltransferase activity by high performance liquid chromatography

Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.

The Association of Aspartate Aminotransferase/Alanine Aminotransferase Ratio with Diabetic Nephropathy in Patients with Type 2 Diabetes

Usefulness of alanine and aspartate aminotransferases in the diagnosis of microlithiasis in idiopathic acute pancreatitis